@article{article, title  = {{A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial}},

 publisher = {{Elsevier}},

 url = {{http://eprints.whiterose.ac.uk/163844/ }},

 year = {{2020}},

 month = {{6}},

 author = {{Peters S and Danson S and Hasan B and Dafni U and Reinmuth N and Majem M and Tournoy KG and Mark MT and Pless M and Cobo M and Rodriguez-Abreu D et al}},

 doi = {{10.1016/j.jtho.2020.06.011}},

 journal = {{Journal of Thoracic Oncology}},

 note = {{Accessed on 2024/09/19}}}